AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Advanced melanoma market seen reaching $6.37 billion by 2030
AGP
The Business Research Company projects the global advanced melanoma market will grow from $4.5 billion in 2026 to $6.37 billion by 2030. The report points to rising melanoma cases, stronger treatment adoption and faster growth in Asia-Pacific,…
Advanced recurrent ovarian cancer market seen reaching $4.01 billion by 2030
AGP
The advanced recurrent ovarian cancer market is projected to grow from $2.71 billion in 2025 to $2.93 billion in 2026, according to The Business Research Company.
Miami Cyber launches free Claude workshops for Florida small businesses
AGP
Miami Cyber is bringing Anthropic-sponsored Claude workshops to Miami, Orlando and Jacksonville for small business owners with 5 to 50 employees.
Danto Builders launches flood resources for South Florida businesses as king tides hit
AGP
Danto Builders is rolling out a video series and free consultations to help South Florida business owners deal with flooding during king tide season.
Ajovy market forecast points to faster growth in migraine prevention
AGP
The Business Research Company says the Ajovy market is set to expand through 2035 as migraine diagnoses rise, preventive treatment gains ground and biologic therapies become more accepted.
Maryann Selfe launches speaking platform on market assumptions and overlooked opportunities
AGP
Investment strategist Maryann Selfe is rolling out “Beyond the Consensus,” a speaking platform aimed at investors and business audiences.
Albuked market seen growing as liver disease demand rises
AGP
The Business Research Company says the global Albuked market has long-term growth potential through 2035, driven by rising liver disease cases, ICU demand and interest in safer non-plasma alternatives.
Aimovig market seen growing on migraine prevention demand
AGP
The Business Research Company says Aimovig’s global market is set to expand through 2035, driven by rising migraine diagnoses, broader insurance coverage, and growing use of preventive biologics.
Afstyla market forecast points to growth through 2035
AGP
The Business Research Company says the Afstyla market is gaining traction as hemophilia A diagnoses rise and more patients move toward recombinant factor VIII therapies.
Afrezza market outlook brightens as diabetes demand rises
AGP
The Business Research Company says the Afrezza market is set for stronger growth through 2035, driven by rising diabetes cases, higher healthcare spending and broader acceptance of inhaled insulin.
Afrezza market outlook brightens on rising diabetes demand
AGP
The Business Research Company says the global Afrezza market is set for stronger growth through 2035 as diabetes cases rise, healthcare spending increases and inhaled insulin gains wider acceptance.
Afluria quadrivalent vaccine market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the global Afluria Quadrivalent vaccine market is being shaped by rising flu incidence, broader pediatric immunization and higher healthcare spending.
AAV market to reach $6.65B by 2030 on gene therapy demand
AGP
The adeno-associated viral vectors market is projected to climb from $3.17 billion in 2025 to $6.65 billion by 2030 as gene therapy activity expands worldwide.
Adstiladrin market report sees growth tied to bladder cancer demand and gene therapy adoption
AGP
The Business Research Company says the global market for Adstiladrin, a gene therapy for high-risk non-muscle-invasive bladder cancer, is being shaped by rising bladder cancer cases, higher healthcare spending, and broader adoption of precision…
Afluria vaccine market seen growing on flu demand and aging population
AGP
The Business Research Company says the Afluria vaccine market is set to expand through 2035, driven by seasonal flu outbreaks, broader vaccination coverage and a growing older population.
ADA-SCID market seen reaching $8.11 billion by 2030
AGP
The Business Research Company says the adenosine deaminase-severe combined immunodeficiency market will rise from $6.33 billion in 2026 to $8.11 billion by 2030. Growth is expected to be driven by more gene therapy, enzyme replacement and stem…
ATP assays market to reach $3.88 billion by 2030
AGP
The adenosine triphosphate (ATP) assays market is projected to grow at a 12.2% CAGR to $3.88 billion by 2030, according to a new Business Research Company report.
Adipose tissue stem cell market seen reaching $2.14 billion by 2030
AGP
The global adipose tissue derived stem cell market is forecast to grow from $1.35 billion in 2026 to $2.14 billion by 2030, driven by regenerative medicine, cell-therapy commercialization and broader clinical use. North America led the market in…
Admelog market seen growing on diabetes demand and biosimilar adoption
AGP
The Business Research Company says the global Admelog market is set for long-term growth through 2035, driven by rising diabetes cases, expanding biosimilar use and government efforts to contain insulin costs.
ARDS market seen reaching $2.42 billion by 2030
AGP
The acute respiratory distress syndrome market is forecast to grow from $1.41 billion in 2025 to $2.42 billion by 2030, driven by rising respiratory illness, ICU expansion and advances in ventilation and ECMO. North America held the largest market…
Sign up for:
Business Post Examiner
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.